Marcus Schmidt
Impact in
- Oncology top 0.2%
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Cancer Treatment and Pharmacology
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Research top 0.5%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
Papers in
- Oncology 177
- HER2/EGFR in Cancer Research 76
- Cancer Treatment and Pharmacology 50
- Cancer Immunotherapy and Biomarkers 25
- Cancer Cells and Metastasis 25
- Cancer Research 102
- Breast Cancer Treatment Studies 90
- Co-authors
- Jan G. Hengstler (39 shared papers)Mathias Gehrmann (24 shared papers)Igor Bondarenko (7 shared papers)Johannes Ettl (6 shared papers)Tamás Pintér (7 shared papers)Katalin Boér (7 shared papers)Richard S. Finn (7 shared papers)Xin Huang (7 shared papers)
- Journals
- Journal of Clinical Oncology (28 papers)Cancer Research (22 papers)Breast Care (17 papers)Breast Cancer Research and Treatment (14 papers)Journal of Cancer Research and Clinical Oncology (13 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Marcus Schmidt
284 papers receiving 8.8k citations
Marcus Schmidt's Hit Papers
Peers
Comparison fields: 5 of 162
- Oncology 5.0k
- Cancer Research 2.7k
- Pulmonary and Respiratory Medicine 2.8k
- Genetics 612
- Biochemistry 265
Countries citing papers authored by Marcus Schmidt
This map shows the geographic impact of Marcus Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Schmidt more than expected).
Fields of papers citing papers by Marcus Schmidt
This network shows the impact of papers produced by Marcus Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Schmidt. The network helps show where Marcus Schmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcus Schmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 297 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study Hit paper breakdown → | 2014 | 1412 |
| 2 | The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer Hit paper breakdown → | 2008 | 588 |
| 3 | Trastuzumab Beyond Progression in Human Epidermal Growth Factor Receptor 2–Positive Advanced Breast Cancer: A German Breast Group 26/Breast International Group 03-05 Study Hit paper breakdown → | 2009 | 504 |
| 4 | 2011 | 250 | |
| 5 | 2013 | 235 | |
| 6 | 2000 | 189 | |
| 7 | 2001 | 185 | |
| 8 | 2014 | 148 | |
| 9 | 2010 | 143 | |
| 10 | 2011 | 141 | |
| 11 | 2016 | 136 | |
| 12 | 1999 | 136 | |
| 13 | 2012 | 129 | |
| 14 | 2013 | 127 | |
| 15 | 2004 | 123 | |
| 16 | 2018 | 117 | |
| 17 | 2002 | 113 | |
| 18 | 2020 | 111 | |
| 19 | 2010 | 111 | |
| 20 | 2010 | 108 |
About Marcus Schmidt
Marcus Schmidt is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Molecular Biology and Genetics, having authored 297 papers that have together received 9.0k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (90 papers), HER2/EGFR in Cancer Research (76 papers), Advanced Breast Cancer Therapies (63 papers), Cancer Treatment and Pharmacology (50 papers), Cancer Immunotherapy and Biomarkers (25 papers), Cancer Cells and Metastasis (25 papers), Ovarian cancer diagnosis and treatment (17 papers) and Endometrial and Cervical Cancer Treatments (16 papers). The work is most often cited by research in Oncology (5.0k citations), Cancer Research (2.7k citations), Pulmonary and Respiratory Medicine (2.8k citations), Genetics (612 citations) and Biochemistry (265 citations). Marcus Schmidt has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Jan G. Hengstler, Mathias Gehrmann, Igor Bondarenko, Johannes Ettl, Tamás Pintér, Katalin Boér, Richard S. Finn, Xin Huang, Dennis J. Slamon and Ravindranath Patel. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Breast Care, Breast Cancer Research and Treatment and Journal of Cancer Research and Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.